News

BioProcessOL
bioprocessonline.com > doc > comparison-of-different-methods-to-isolate-hmw-dna-from-bacteria-for-nanopore-sequencing-0001

Comparison Of Different Methods To Isolate HMW DNA From Bacteria For Nanopore Sequencing

1+ hour, 39+ min ago  (171+ words) Comparison Of Different Methods To Isolate HMW DNA From Bacteria For Nanopore Sequencing'Bioprocess Online Comparison Of Different Methods To Isolate HMW DNA From Bacteria For Nanopore Sequencing By Christina Engesser, NGS Competence Center T'bingen, and Whitney Pike, Agilent Technologies Achieving…...

BioProcessOL
bioprocessonline.com > doc > improvements-in-adc-efficacy-and-stability-through-proprietary-hydrophilic-linker-platform-0001

Improvements In ADC Efficacy And Stability Through Proprietary Hydrophilic Linker Platform

1+ week, 3+ day ago  (235+ words) Improvements In ADC Efficacy And Stability Through Proprietary Hydrophilic Linker Platform'Bioprocess Online Improvements In ADC Efficacy And Stability Through Proprietary Hydrophilic Linker Platform Antibody-drug conjugates (ADCs) are transforming oncology by combining the targeting specificity of monoclonal antibodies with highly potent…...

BioProcessOL
bioprocessonline.com > doc > cogs-and-biology-two-endpoints-needlessly-at-odds-in-advanced-therapy-0001

COGs And Biology, Two Endpoints Needlessly At Odds In Advanced Therapy

1+ week, 4+ day ago  (1420+ words) Guest Column | March 20, 2026 By Arnaud Deladeriere, Ph.D., Cell&Gene Consulting Inc. Over the past decade, cell and gene therapy has moved from early academic programs to a growing number of commercial-stage products. As the field matures, attention has increasingly shifted…...

BioProcessOL
bioprocessonline.com > doc > clearing-the-fog-on-new-first-air-visualization-expectations-0001

Clearing The Fog On New First Air Visualization Expectations

1+ week, 6+ day ago  (444+ words) Guest Column | March 18, 2026 A conversation with Takeshi Ono, Daiichi Sankyo, and Masaru Fujita, Kyowa Kirin A cleanroom is only as safe as the air moving within it. Regulators are increasingly scrutinizing first air, the undisturbed unidirectional flow exiting HEPA filters,…...

BioProcessOL
bioprocessonline.com > doc > trends-in-fda-fy-2025-warning-letters-0001

Trends In FDA FY 2025 Warning Letters

2+ week, 4+ day ago  (520+ words) Guest Column | March 13, 2026 By Erin Hartmann and Liz Oestreich, ELIQUENT Life Sciences Finally, two letters were issued exclusively for failure to register and list; however, registration and listing failures were also noted in one warning letter following a 704(a)(4) request and…...

BioProcessOL
bioprocessonline.com > doc > preventive-control-of-sequencing-through-the-insert-with-the-agilent-fragment-analyzer-system-0001

Preventive Control Of Sequencing Through The Insert With The Agilent 5200 Fragment Analyzer System

2+ week, 4+ day ago  (158+ words) Preventive Control Of Sequencing Through The Insert With The Agilent 5200 Fragment Analyzer System'bioprocessonline.com Preventive Control Of Sequencing Through The Insert With The Agilent 5200 Fragment Analyzer System By Vera Rykalina and Kyle Luttgeharm, Agilent Technologies Choosing the right read length…...

BioProcessOL
bioprocessonline.com > doc > accelerating-technology-diffusion-in-cell-and-gene-therapy-0001

Accelerating Technology Diffusion In Cell And Gene Therapy

2+ week, 6+ day ago  (501+ words) Guest Column | March 11, 2026 By Partha Anbil, Life Sciences Industry Advisor, MIT Sloan, and Mamta Malhotra, consultant The California Institute for Regenerative Medicine (CIRM) exemplifies this principle. Through $5.5 billion in state funding since 2004, CIRM has directly supported absorptive capacity development by…...

BioProcessOL
bioprocessonline.com > doc > tailoring-viral-clearance-study-design-to-regulatory-requirements-and-real-world-demands-0001

Tailoring Viral Clearance Study Design To Regulatory Requirements And Real-World Demands

3+ week, 3+ day ago  (203+ words) Tailoring Viral Clearance Study Design To Regulatory Requirements And Real-World Demands'Bioprocess Online Tailoring Viral Clearance Study Design To Regulatory Requirements And Real-World Demands Ensuring viral safety in biologics and advanced therapies depends on robust clearance studies that complement material characterization…...

BioProcessOL
bioprocessonline.com > doc > minaris-beyond-the-rfp-key-selection-criteria-for-cell-gene-therapy-cdmos-0001

Minaris Beyond the RFP: Key Selection Criteria For Cell & Gene Therapy CDMOs

3+ week, 5+ day ago  (754+ words) Minaris Beyond the RFP: Key Selection Criteria For Cell & Gene Therapy CDMOs'Bioprocess Online We value your privacy - Description This cookie, set by Cloudflare, is used to support Cloudflare Bot Management. - Description Google Recaptcha service sets this cookie to identify bots…...

BioProcessOL
bioprocessonline.com > doc > a-biotech-business-model-to-convince-investors-0001

A Biotech Business Model That's Investor-Friendly

4+ week, 1+ day ago  (948+ words) From The Editor | March 2, 2026 By Louis Garguilo, Chief Editor, Outsourced Pharma For biotechs meeting with current and potential investors, says Edward Ahn, CEO, Medipost Inc., "it should be about demonstrating your business continuity more than anything else." That's what he…...